Background Anogenital warts (AGW) can cause economic burden on healthcare systems
and are associated with emotional, psychological and physical issues. Objective To provide …

Background Although new HPV vaccines have been developed and are in the process of
implementation, anogenital warts remain a very frequent problem in clinical practice …

This article critically reviews both established and experimental treatment modalities for
anogenital (AG) warts. Efficacy, cost, safety, advantages and disadvantages of each therapy …

This guideline is an update of the 2011 European Guideline for the Management of
Anogenital Warts. It is intended to support best practice in the care of patients with …

Abstract Background Anogenital warts (AGWs) are a common, highly infectious disease
caused by the human papillomavirus (HPV), whose high recurrence rates contribute to direct …

Background Anogenital warts (AGWs, condylomata acuminata) are among the most
common STIs and may severely impact quality of life (QoL). Available treatment options are …

Objective To generate estimates of comparative clinical effectiveness for interventions used
in the treatment of anogenital warts (AGWs) through the systematic review, appraisal and …

BACKGROUND Typically occurring on the external genitalia, anogenital warts (AGWs) are
benign epithelial skin lesions caused by human papillomavirus infection. AGWs are usually …

The primary goal of treatment for external genital warts (EGWs) is to eradicate visible lesions
and address symptoms that may accompany them, but it does not address the underlying …

Anogenital warts (AGWs) rank among the most frequent sexually transmitted infections in
young adults. They are benign lesions, but they pose a significant economic cost to health …